FDA issued a Warning Letter to Amgen, Inc. on 5/9/2003 as a result of this inspection.
483 Amgen Jan 2003$595.00 - Available Now
FDA investigators audited the Amgen - Boulder, CO, United States facility and issued inspectional observations (via FDA 483) on 24 Jan 2003.
Add To Cart
- Category: Biologics
- Inspection end: 24 Jan 2003
- Location: Boulder, United States
- FEI: 3003072024